These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9233468)

  • 1. Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1-infected antiviral-naive patients from 1989 to 1996.
    Rubio A; Leal M; Pineda JA; Caruz A; Luque F; Rey C; Sanchez-Quijano A; Lissen E
    AIDS; 1997 Jul; 11(9):1184-6. PubMed ID: 9233468
    [No Abstract]   [Full Text] [Related]  

  • 2. Infection by zidovudine-resistant HIV-1 compromises the virological response to stavudine in a drug-naive patient.
    de Ronde A; van Dooren M; de Rooij E; van Gemen B; Lange J; Goudsmit J
    AIDS; 2000 Nov; 14(16):2632-3. PubMed ID: 11101087
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.
    Gómez-Cano M; Rubio A; Puig T; Pérez-Olmeda M; Ruiz L; Soriano V; Pineda JA; Zamora L; Xaus N; Clotet B; Leal M
    AIDS; 1998 Jun; 12(9):1015-20. PubMed ID: 9662197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of HIV-1 variants harbouring the zidovudine resistance mutation at pol codon 215 in patients who respond to triple combination therapy.
    Batisse D; Karmochkine M; Si Mohamed A; Piketty C; Kazatchkine MD; Belec L
    AIDS; 1998 May; 12(7):824-5. PubMed ID: 9619820
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-term evolution of HIV-1 viraemia and CD4+ cell counts in patients who have a primary mutation to zidovudine.
    Rubio A; Leal M; Rey C; Pineda JA; Sanchez-Quijano A; Lissen E
    AIDS; 1998 Mar; 12(4):395-8. PubMed ID: 9520169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of primary resistance to zidovudine and lamivudine in drug-naive human immunodeficiency virus type-1 infected patients: high proportion of reverse transcriptase codon 215 mutant in circulating lymphocytes and free virus.
    Trabaud MA; Leriche-Guerin K; Regis C; Bordes I; Cotte L; Detmer J; Kolberg J; Ritter J; Trépo C
    J Med Virol; 2000 Jul; 61(3):352-9. PubMed ID: 10861645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of acute HIV-1 infection: zidovudine-resistant isolates compared with zidovudine-sensitive isolates.
    Vanhems P; Gaudet R; Hirschel B; Imrie A; Conway B; Rouleau D; Vizzard J; Perrin L; Cooper DA; Yerly S
    AIDS; 2000 May; 14(8):1065-7. PubMed ID: 10853993
    [No Abstract]   [Full Text] [Related]  

  • 8. Overview on HIV-1-related drug resistance: from theory to clinical practice.
    Moroni M; Balotta C; Rusconi S
    J Biol Regul Homeost Agents; 1998; 12(1-2 Suppl):15-8. PubMed ID: 9689573
    [No Abstract]   [Full Text] [Related]  

  • 9. Frequency of drug-resistant variants of HIV-1 coexistent with wild-type in treatment-naive patients of India.
    Sachdeva N; Sehgal S; Arora SK
    MedGenMed; 2005 Jul; 7(3):68. PubMed ID: 16369294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations associated with zidovudine resistance in HIV-1 among recent seroconvertors.
    Quigg M; Rebus S; France AJ; McMenamin J; Darby G; Leigh Brown AJ
    AIDS; 1997 May; 11(6):835-6. PubMed ID: 9143628
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995--1999.
    Sitnitskaya Y; Rochford G; Rigaud M; Essajee S; Pollack H; Krasinski K; Borkowsky W
    Clin Infect Dis; 2001 Jul; 33(1):e3-7. PubMed ID: 11389511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus-infected persons with mutations conferring resistance to zidovudine show reduced virologic responses to hydroxyurea and stavudine-lamivudine.
    Montaner JS; Mo T; Raboud JM; Rae S; Alexander CS; Zala C; Rouleau D; Harrigan PR
    J Infect Dis; 2000 Feb; 181(2):729-32. PubMed ID: 10669364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team.
    Kuritzkes DR; Sevin A; Young B; Bakhtiari M; Wu H; St Clair M; Connick E; Landay A; Spritzler J; Kessler H; Lederman MM
    J Infect Dis; 2000 Feb; 181(2):491-7. PubMed ID: 10669331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 resistance genotyping by sequencing produces inconsistent results for mixed viral populations.
    Frater AJ; Chaput CC; Weber JN; McClure MO
    AIDS; 2000 Jul; 14(10):1473-5. PubMed ID: 10930175
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutations in the HIV type 1 integrase of patients receiving long-term dideoxynucleoside therapy do not confer resistance to zidovudine.
    Pilon AA; Marchand C; Kavlick MF; Bajaj K; Owen J; Mitsuya H; Pommier Y
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1417-22. PubMed ID: 11018861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission of zidovudine-resistant HIV-1 through heterosexual contacts.
    Angarano G; Monno L; Appice A; Giannelli A; Romanelli C; Fico C; Pastore G
    AIDS; 1994 Jul; 8(7):1013-4. PubMed ID: 7524541
    [No Abstract]   [Full Text] [Related]  

  • 17. Human immunodeficiency virus proviral DNA from peripheral blood and lymph nodes demonstrates concordant resistance mutations to zidovudine (codon 215) and didanosine (codon 74). Division of AIDS Treatment Research Initiative 003 Study Group.
    Mayers D; Bethel J; Wainberg MA; Weislow O; Schnittman S
    J Infect Dis; 1998 Jun; 177(6):1730-3. PubMed ID: 9607859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication.
    Naeger LK; Margot NA; Miller MD
    Antivir Ther; 2001 Jun; 6(2):115-26. PubMed ID: 11491416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antiretroviral resistance in a South London cohort of treatment-naive HIV-1-infected patients.
    Geretti AM; Smith M; Osner N; O'Shea S; Chrystie I; Easterbrook P; Zuckerman M
    AIDS; 2001 May; 15(8):1082-4. PubMed ID: 11400002
    [No Abstract]   [Full Text] [Related]  

  • 20. Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. Sydney Primary HIV Infection Study Group.
    Imrie A; Beveridge A; Genn W; Vizzard J; Cooper DA
    J Infect Dis; 1997 Jun; 175(6):1502-6. PubMed ID: 9180194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.